Alexander Milstein, formerly vice president of clinical development at Cytori Therapeutics Inc, has joined Cardio3 BioSciences SA as vice president of clinical development. He comes to the Belgian company as it prepares to bring its autologous stem-cell treatment for heat failure into Phase 3 development. Dr Milstein holds a medical degree from the Moscow Medical University and started his career in clinical development as a research fellow at Harvard University and the Massachusetts General Hospital.
Cardio3 BioSciences announced the appointment on 21 August 2012.
Copyright 2012 Evernow Publishing Ltd